Working together to develop a screening platform to enhance the detection and management of Alzheimer’s disease.
PREDICTOM is an international across sector initiative to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Latest news
News
👁️🗨️Eyes on the Future: How Eye-Tracking Could Transform Early Dementia Detection
Eye-tracking technology is emerging as a promising tool for early detection of cognitive decline. By analyzing involuntary eye movements, researchers can identify subtle cognitive and attentional changes that may accompany the earliest stages of mild cognitive impairment and Alzheimer’s disease — sometimes before these changes are evident on traditional paper-based tests. This article explores the science, clinical applications, and innovations driving this breakthrough.
News
🦻Hearing Loss and Dementia: A Silent Link with Loud Consequences
PREDICTOM clinical study has now been launched. The study is recruiting healthy people who are based in UK, Norway, Spain, Geneva, Germany, France and Brussels. Are you interested in our study? Are you uncertain about the tests involved? Why do we have these tests? Are they able to detect early-signs of dementia? To take you insde our study, explore the different tests and methods involved, we will publish a series of news articles dedicated to the PREDICTOM clinical study. In the first article of the series, we are presenting the hearing test.
News
🧲 New MRI Technique to Speed Up Multi-Contrast MRI Scans and Advance Early Alzheimer’s Biomarker Discovery
A new publication from PREDICTOM introduces a promising method to dramatically accelerate multi-contrast brain MRI scans, without sacrificing image quality. The technique could pave the way for earlier and more accessible diagnosis of neurodegenerative diseases like Alzheimer’s disease.
Did you know that you can reduce your risk of developing dementia?
The risk of developing dementia is influenced by various factors, with several of them being modifiable by the actions we take on a daily basis. On this page you can learn more about what actions you can take to reduce your risk.
Our mission
PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.